Royal Bank of Canada’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-36,000
Closed -$2.45M 6584
2015
Q4
$2.45M Buy
+36,000
New +$2.17M ﹤0.01% 2372

Other funds holding PRTA

Royal Bank of Canada's PRTA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Prothena Corp (PRTA) stake by 28% in Q1 2026, selling an estimated $11.5K and leaving 3,171 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #5726.

Royal Bank of Canada first reported a position in PRTA in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.89M in Q4 2015. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Royal Bank of Canada held 3,171 shares of Prothena Corp worth $30K as of Q1 2026.
  • Royal Bank of Canada sold 1,256 Prothena Corp shares in Q1 2026, an estimated $11.5K.
  • Prothena Corp made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5726 holding.
  • Royal Bank of Canada first reported a position in Prothena Corp in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Prothena Corp position peaked at $4.89M in Q4 2015.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.